Contractile effects of 5-hydroxytryptamine and 5-carboxamidotryptamine in the equine jejunum

British Journal of Pharmacology

Volumn 147, Issue 1, 2006, Pages 23-35

  Delesalle, Cathérine ^a   Deprez, Piet ^a   Schuurkes, Jan A J ^b   Lefebvre, Romain A ^c  

^a GHENT UNIVERSITY   (Belgium)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

5 CT; 5 HT; Colic; Equine small intestine; Horse; Ileus; Serotonin

Indexed keywords

1 (1 METHYL 5 INDOLYL) 3 (3 METHYL 5 ISOTHIAZOLYL)UREA; 1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 5 CARBAMOYLTRYPTAMINE; 8 [4 (5 AMINO 2,4 DIMETHOXYBENZOYL)BUTYL] 1,3,8 TRIAZASPIRO[4.5]DECANE 2,4 DIONE; ATROPINE; BUSPIRONE; FLESINOXAN; GRANISETRON; KETANSERIN; METHYSERGIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN; SEROTONIN 2B RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN ANTAGONIST; TETRODOTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HORSE; HUMAN; JEJUNUM; MALE; MOTOR PERFORMANCE; MUSCLE CONTRACTION; MUSCLE ISOTONIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 30344458810     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706431     Document Type: Article

References (63)

1. AHLERS, S.T., WEISSMAN, B.A. & BARRETT, J.E. (1992). Antagonism studies with BMY-7378 and NAN 190 - effects on 8-hydroxy-2-(di-normal- propylamino)tetralin-induced increases in punished responding of pigeons. J. Pharmacol. Exp. Ther., 260, 474-481.
2. BAILEY, S.R., CUNNINGHAM, F.M. & ELLIOTT, J. (2000). Endotoxin and dietary amines may increase plasma 5-hydroxytryptamine in the horse. Eq. Vet. J., 32, 497-504.
3. BAILEY, S.R., MARR, C.M. & ELLIOTT, J. (2003). Identification and quantification of amines in the equine caecum. Res. Vet. Sci., 74, 113-118.
4. BAILEY, S.R., MENZIES-GOW, N.J., MARR, C.M. & ELLIOTT, J. (2004). The effects of vasoactive amines found in the equine hindgut on digital blood flow in the normal horse. Eq. Vet. J., 36, 267-272.
5. 3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism. Eur. J. Pharmacol., 178, 179-187.
6. 1A agonist actions of 5-carboxamidotryptamine in the isolated transmurally stimulated ileum of the guinea-pig. Br. J. Pharmacol., 100, 483.
7. BONHAUS, D.W., WEINHARDT, K.K., TAYLOR, M., DESOUZA, A. & McNEELEY, P.M. (1997). RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology, 36, 621-629.
8. BRIANCEAU, P., CHEVALIER, H., KARAS, A., COURT, M.H., BASSAGE, L. & KIRKER-HEAD, C. (2002). Intravenous Lidocaine and small-intestinal size, abdominal fluid, and outcome after colic surgery in horses. J. Vet. Intern. Med., 16, 736-741.
9. BUCHHEIT, K.H. & BUHL, T. (1994). Stimulant effects of 5-hydroxytryptamine on guinea-pig stomach preparations in-vitro. Eur. J. Pharmacol., 262, 91-97.
10. CAO, B.J. & RODGERS, R.J. (1997). Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190. Pharmacol. Biochem. Behav., 58, 593-603.
11. CHANDA, P.K., MINCHIN, M.C., DAVIS, A.R., GREENBERG, L. & REILLY, Y. (1993). Identification of residues important for ligand binding to the human 5-hydroxytryptaminelA serotonin receptor. J. Exp. Pharmacol. Ther., 43, 516-520.
12. 1A receptors couple to activation of Akt, but not extracellular-regulated kinase (ERK), in cultured hippocampal neurons. J. Neurochem., 93, 910-917.
13. DELLA ROCCA, G.J., MUKHIN, Y.V., GARNOVSKAYA, M.N., DAAKA, Y., CLARK, G.J., LUTTRELL, L.M., LEFKOWITZ, R.J. & RAYMOND, J.R. (1999). Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis. J. Biol. Chem., 274, 4749-4753.
14. 1A receptor mediated inhibition of of acetylcholine release from guinea-pig myenteric plexus: potential mechanisms. Neuropharmacology, 35, 483-488.
15. ELLIOTT, J., BERHANE, Y. & BAILEY, S.R. (2003). Effects of monoamines formed in the cecum of horses on equine digital blood vessels and platelets. Am. J. Vet. Res., 64, 1124-1131.
16. 1A receptor antagonist. Br. J. Pharmacol., 122, 91.
17. FORBES, I.T., JONES, G.E. & MURPHY, O.E. (1995). N-(1-methyl-5- indolyl)-N′-(3-methyl-5-isothiazolyl)urea: a novel, high affinity 5-HT2B receptor antagonist. J. Med. Chem., 38, 855-857.
18. 1A receptor antagonist WAY 100635. Eur. J. Pharmacol., 281, 81-88.
19. GALLIGAN, J.J. (1996). Electrophysiological studies of 5-hydroxytryptamine receptors on enteric neurones. Behav. Brain Res., 73, 199-201.
20. 1 receptors on myenteric and submucosal neurons. Am. J. Physiol., 255, 603-611.
21. GERRING, E.E.L. & HUNT, J.M. (1986). Pathophysiology of equine postoperative ileus: effects of adrenergic blockade, parasympathetic stimulation and metoclopramide in an experimental model. Eq. Vet. J., 18, 249-255.
22. GOMMEREN, W., RENDERS, J., VAN COMPEL, P., LESAGE, A., LEYSEN, J.E. & JURZAK, MT. (1998). Extensive pharmacological study of the G-protein coupled fraction of human 5-HT receptors using agonist radioligand binding. Naunyn Schmiedebergh's Arch. Pharmacol., 358, 8-42.
23. 1A receptors. Mol. Pharmacol., 41, 695-698.
24. HADRAVA, V., BLIER, P., DENNIS, T., ORTEMANN, C. & DE MONTIGNY, C. (1995). Characterization of 5-hydroxytryptamine(1A) properties of flesinoxan-in-vivo electrophysiology and hypothermia study. Neuropharmacology, 34, 1311-1326.
25. HAGAN, J.J., PRICE, G.W., JEFFREY, P., DEEKS, N.J., STEAN, T., PIPER, D., SMITH, M.I., UPTON, N., MEDHURST, A.D., MIDDLEMISS, D.N., RILEY, G.J., LOVELL, P.J., BROMIDGE, S.M. & THOMAS, D.R. (2000). Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist. Br. J. Pharmacol., 130, 539-548.
26. HALL, H., LUNDKVIST, C., HALLDIN, C., FARDE, L., PIKE, V.W., McCARRON, J.A., FlETCHER, A., CLIFFE, I.A., BARF, T., WIKSTRÖM, H. & SEDVALL, G. (1997). Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [H-3]WAY-100635 and [C-11]WAY-100635. Brain Res., 745, 96-108.
27. HENSLER, J.G. & DURGAM, H. (2001). Regulation of 5-HT1A receptor-stimulated [S-35]-GTP gamma S binding as measured by quantitative autoradiography following chronic agonist administration. Br. J. Pharmacol., 132, 605-611.
28. 1A receptor: a site-directed mutagenesis study. FEBS Lett., 312, 259-262.
29. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol. Rev., 46, 157-203.
30. 2 receptor. Eur. J. Pharmacol., 239, 111-118.
31. 3H] WAY 100635. Life Sci., 60, 653-665.
32. 1A receptor antagonist, to rat brain. J. Neorochem., 64, 2716-2726.
33. 2 receptors. Eur. J. Pharmacol., 166, 315-318.
34. 1p receptors. J. Comp. Neurol., 327, 233-250.
35. 1A receptors in the nervous systems of the bowel and pancreas. J. Comp. Neurol., 364, 439-455.
36. b from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation. TiPS, 14, 237-239.
37. LEPARD, K.J. & GALLICAN, J.J. (2004). Presynaptic modulation of cholinergic and non-cholinergic fast synaptic transmission in the myenteric plexus of guinea pig ileum. Neurogastroenterol. Motil., 16, 355-364.
38. LIPPOLD, B.S., HILDEBRAND, J. & STRAUB, R. (2004). Tegaserod (HTF 919) stimulates gut motility in normal horses. Eq. Vet. J., 36, 622-627.
39. MENZIES-GOW, N.J., BAILEY, S.R., KATZ, L.C., MARR, C.M. & ELLIOTT, J. (2004). Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators. Eq. Vet. J., 36, 273-278.
40. MOLLER, M., CUMMING, P., ANDERSEN, G. & GJEDDE, A. (2004). Parametric mapping of serotonin5HT1Areceptors in healthy humanbrain. Neuroimage, 22, T157.
41. MORRIS, D.D. (1991). Endotoxemia in horses. A review of cellular and humoral mediators involved in its pathogenesis. J. Vet. Intern. Med., 5, 167-181.
42. NEBIGIL, C.G., GARNOVSKAYA, M.N., CASANAS, S.J., MULHERON, J.G., PARKER, E.M., GETTYS, T.W. & RAYMOND, J.R. (1995). Agonist-induced desensitization and phosphorylation of human 5-HT1A receptors expressed in SF9 insect cells. Biochemistry, 34, 11954-11962.
43. NEWMAN-TANCREDI, A., VERRIELE, L. & MILLAN, M.J. (2001). Differential modulation by GTP gamma S of agonist and inverse agonist binding to h5-HT1A receptors revealed by [H-3]-WAY100635. Br. J. Pharmacol., 132, 518-524.
44. 35S] GTPγS binding study. Eur. J. Pharmacol., 355, 245-256.
45. NIETO, J.E., SNYDER, J.R., KOLLIAS-BAKER, C. & STANLEY, S. (2000). In vitro effects of 5-hydroxytryptamine and cisapride on the circular smooth muscle of the jejunum of horses. Am. J. Vet. Res., 61, 1561-1565.
46. 1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells. Biochem. Pharmacol., 45, 375-383.
47. PAZOS, A. & PALACIOS, J.M. (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. Brain Res., 346, 205-230.
48. 1A receptor: G protein coupling and signalling pathways. Br. J. Pharmacol., 127, 1751-1764.
49. RIAD, M., WATKINS, K.C., DOUCET, E., HAMON, M. & DESCARRIES, L. (2001). Agonist-induced internalization of serotonin-1A receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J. Neurosci., 21, 8378-8386.
50. ROTONDO, A., NIELSEN, D.A., NAKHAI, B., HULIHAN-GIBLIN, B., BOLOS, A. & GOLDMAN, D. (1997). Agonist-promoted down-regulation and functional desensitization in two naturally occurring variants of the human serotonin(1A) receptor. Neuropsychopharmacology, 17, 18-26.
51. ROUSSEL, A.J., COHEN, N.D., HOOPER, R.N. & RAKESTRAW, P.C. (2001). Risk factors associated with development of postoperative ileus in horses. J. Am. Vet. Med. Assoc., 219, 72-78.
52. SANGER, D.J. & SCHOEMAKER, H. (1992). Discriminative stimulus properties of 8-OH-DPAT: relationship to affinity for 5HT1A receptors. Psychopharmacology, 108, 85-92.
53. SANGER, G. & NELSON, D.R. (1989). Selective and functional 5-hydroxytryptamine 3 receptor antagonism by BRL 43694 (granisetron). Eur. J. Pharmacol., 159, 113-124.
54. SERRES, F., MUMA, N.A., RAAP, D.K., GARCIA, F., BATTAGLIA, G. & VAN DE KAR, L.D. (2000). Coadministration of 5-hydroxytryptamine (1A) antagonist WAY-100635 prevents fluoxetine-induced desensitization of postsynaptic 5-hydroxytryptamine (1A) receptors in hypothalamus. J. Pharmacol. Exp. Ther., 294, 296-301.
55. 1A receptors to 8-OH-DPAT: an in vivo spinal reflex study. Neuro Rep, 8, 2489-2493.
56. SHARIF, N.A., DRACE, C.D., WILLIAMS, G.W. & CRIDER, J.Y. (2004). Cloned human 5-HT1A receptor pharmacology determined using agonist binding and measurement of cAMP accumulation. J. Pharm. Pharmacol., 56, 1267-1274.
57. SHIRAKAWA, J., TAKEDA, K., TANIYAMA, K. & TANAKA, C. (1989). Dual effects of 5-hydroxytryptamine on the release of G-aminobutyric acid from myenteric neurones of the guinea-pig ileum. Br. J. Pharmacol., 98, 339-341.
58. SNYDER, J.R. (1989). The pathophysiology of intestinal damage: effects of luminal distention and ischemia. Vet. Clin. North. Am. Equine Pract, 5, 247-270.
59. TALLEY, N.J. (2001). Serotoninergic neuroenteric modulators. Lancet, 15, 2061-2068.
60. TERRON, J. A. (1996). GR 127935 is a potent antagonist of the 5-HT1-like receptor mediating contraction in the canine coronary artery. Eur. J. Pharmacol., 300, 109-112.
61. VAN HOOGMOED, L.M., NIETO, J.E. & SNYDER, J.R. (2004). Survey of prokinetic use in horses with gastrointestinal injury. Vet. Surg., 33, 279-285.
62. VATISTAS, N.J., NIETO, J.E., VAN HOOGMOED, L., GARDNER, I. & SNYDER, J.R. (2003). Use of an isolated intestinal circuit to evaluate the effect of ischemia and reperfusion on mucosal permeability of the equine jejunum. Vet. Surg., 32, 52-61.
63. 4 agonist. J. Vet. Pharmacol. Ther., 25, 49-58.